Shopping Cart 0
Cart Subtotal
USD 0

Europe HLA Typing Transplant Diagnostics Services Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 3200
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Europe HLA typing transplant diagnostics services market is expected to reach USD 282.53 million by 2025, from USD 140.58 million in 2017 growing at a CAGR of 9.2% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors driving the growth of this market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the global HLA typing transplant diagnostics services market. On the other hand, weak reimbursements for organ donation and transplantation procedures, expensive NGS and PCR-based devices may hinder the growth of the market.

The key market players for Europe HLA typing transplant diagnostics services market are listed below:

Proimmune Ltd.

Creative Biolabs

Histogenetics LLC

The UCLA Immunogenetics Center

Admera Health, Quick Biology

New York Blood Center

The Sequencing Center

BloodCenter of Wisconsin

Laboratory Corporation of America Holdings

One Lambda (Thermo Fischer Scientific, InC.)

The market is further segmented into:

Technology

End-User

The Europe HLA typing transplant diagnostics services market is segmented based on technology into polymerase chain reaction (PCR), and next-generation sequencing (NGS). In 2018, polymerase chain reaction (PCR) segment is expected to dominate the Europe HLA typing transplant diagnostics services market with 61.8% market share and is expected to reach USD 172.37 million by 2025, with a CAGR of 9.0% in the forecast period 2018 to 2025. However, Next-Generation Sequencing (NGS) is expected to grow at the highest CAGR of 9.5% in the forecast period, and is expected to reach USD 110.16 million in 2025 from USD 53.61 million in 2017.

The polymerase chain reaction (PCR) is further sub segmented on the basis of techniques into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide), and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) segment is expected to dominate the Europe HLA typing transplant diagnostics services market with 56.1% market share and is expected to reach USD 155.76 million by 2025, with the CAGR of 8.9% in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) segment is expected to grow at the highest CAGR of 9.8% in the forecast period, and is expected to reach USD 41.59 million in 2025 from USD 19.84 million in 2017.

The Europe HLA typing transplant diagnostics services market is segmented on the basis of end users into hospitals, transplant centers, specialty clinics, and academic institutes. In 2018, hospitals segment is expected to dominate the Europe HLA typing transplant diagnostics services market with 53.0% market share and is expected to reach USD 152.93 million by 2025, with the highest CAGR of 9.5% in the forecast period 2018 to 2025.

Based on geography, the market is segmented into:

Germany

France

U.K.

Spain

Italy

Switzerland

Netherlands

Russia

Turkey

Belgium

Rest of Europe

Covered in this report

The report covers the present scenario and the growth prospects of the Europe HLA typing transplant diagnostics services for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1. Introduction 15

1.1. Objectives Of The Study 15

1.2. Market Definition 15

1.3. Overview Of Europe Hla Typing Transplant Diagnostics Services Market 15

1.4. Currency And Pricing 16

1.5. Limitation 16

1.6. Markets Covered 17

2. Market Segmentation 19

2.1. Markets Covered 19

2.2. Geographic Scope 20

2.3. Years Considered For The Study 21

2.4. Currency And Pricing 21

2.5. Research Methodology 22

2.6. Primary Interviews With Key Opinion Leaders 25

2.7. Secondary Sources 26

2.8. Assumptions 26

3. Market Overview 27

3.1. Drivers 29

3.1.1. Technological Advancements In Hla Typing 29

3.1.2. Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures 30

3.1.3. Increased Research Grants, Funds, And Public-Private Investments 30

3.2. Restraints 31

3.2.1. Weak Reimbursements For Organ Donation And Transplantation Procedures 31

3.2.2. Expensive Ngs And Pcr-Based Devices 31

3.3. Opportunities 32

3.3.1. Rising Healthcare Infrastructure In Emerging Nations 32

3.4. Challenges 33

3.4.1. Significant Gap Between Number Of Organs Donated And Organs Required Annually 33

3.4.2. Lack Of Trained Staff 34

4. Executive Summary 35

5. Premium Insights 37

6. Europe Hla Typing Transplant Diagnostics Services Market, By Technology 40

6.1. Overview 41

6.2. Next-Generation Sequencing (Ngs) 43

6.3. Polymerase Chain Reaction (Pcr) 44

6.3.1. Pcr Ssop (Sequence-Specific Oligonucleotide) 45

6.3.2. Pcr Ssp (Sequence-Specific Primer) 45

6.3.3. Pcr-Sbt (Sequencing Based Typing) 46

7. Europe Hla Typing Transplant Diagnostics Services Market, By End-User 47

7.1. Overview 48

7.2. Specialty Clinics 50

7.3. Hospitals 51

7.4. Transplant Centers 52

7.5. Academic Institutes 53

8. Europe Hla Typing Transplant Diagnostics Services Market, By Geography 54

8.1. Europe 54

8.1.1. Germany 63

8.1.2. France 65

8.1.3. U.K. 67

8.1.4. Italy 69

8.1.5. Spain 71

8.1.6. Switzerland 73

8.1.7. Netherlands 75

8.1.8. Belgium 77

8.1.9. Russia 79

8.1.10. Turkey 81

8.1.11. Rest Of Europe 83

9. Europe Hla Typing Transplant Diagnostics Services Market, Company Landscape 84

9.1. Company Share Analysis: Europe 84

10. Company Profiles 85

10.1. Proimmune Ltd. 85

10.1.1. Company Overview 85

10.1.2. Proimmune Ltd.: Company Snapshot 85

10.1.3. Product Portfolio 86

10.1.4. Recent Developments 86

10.2. Creative Biolabs 87

10.2.1. Company Overview 87

10.2.2. Creative Biolabs: Company Snapshot 87

10.2.3. Product Portfolio 87

10.2.4. Recent Developments 87

10.3. Histogenetics Llc 88

10.3.1. Company Overview 88

10.3.2. Histogenetics Llc: Company Snapshot 88

10.3.3. Product Portfolio 88

10.3.4. Recent Developments 88

10.4. The Ucla Immunogenetics Center 89

10.4.1. Company Overview 89

10.4.2. The Ucla Immunogenetics Center: Company Snapshot 89

10.4.3. Product Portfolio 89

10.4.4. Recent Developments 89

10.5. Admera Health 90

10.5.1. Company Overview 90

10.5.2. Admera Health: Company Snapshot 90

10.5.3. Product Portfolio 91

10.5.4. Recent Developments 91

10.6. Quick Biology 92

10.6.1. Company Overview 92

10.6.2. Quick Biology: Company Snapshot 92

10.6.3. Product Portfolio 92

10.6.4. Recent Developments 92

10.7. New York Blood Center 93

10.7.1. Company Overview 93

10.7.2. New York Blood Center: Company Snapshot 93

10.7.3. Product Portfolio 93

10.7.4. Recent Developments 93

10.8. The Sequencing Center 94

10.8.1. Company Overview 94

10.8.2. The Sequencing Center: Company Snapshot 94

10.8.3. Product Portfolio 95

10.8.4. Recent Developments 95

10.9. Bloodcenter Of Wisconsin 96

10.9.1. Company Overview 96

10.9.2. Bloodcenter Of Wisconsin: Company Snapshot 96

10.9.3. Product Portfolio 96

10.9.4. Recent Developments 96

10.10. Laboratory Corporation Of America Holdings 97

10.10.1. Company Overview 97

10.10.2. Laboratory Corporation Of America Holdings: Revenue Analysis 97

10.10.3. Product Portfolio 98

10.10.4. Recent Developments 98

10.11. Thermo Fisher Scientific Inc. 99

10.11.1. Company Overview 99

10.11.2. Thermo Fisher Scientific Inc. :Revenue Analysis 99

10.11.3. Product Portfolio 100

10.11.4. Recent Developments 100

11. Related Reports 101


List Of Figure

Figures List

Figure 1 Europe Hla Typing Transplant Diagnostics Services Market: Segmentation 19

Figure 2 Europe Hla Typing Transplant Diagnostics Services Market: Data Triangulation 22

Figure 3 Europe Hla Typing Transplant Diagnostics Services Market: Research Snapshot 23

Figure 4 Europe Hla Typing Transplant Diagnostics Services Market: Bottom Up Approach 24

Figure 5 Europe Hla Typing Transplant Diagnostics Services Market: Top Down Approach 24

Figure 6 Europe Hla Typing Transplant Diagnostics Services Market: Interview Demographics 25

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Europe Hla Typing Transplant Diagnostics Services Market 28

Figure 8 Healthcare Expenditure In Few Emerging Countries (2000, 2010 & 2014) 32

Figure 9 Number Of Donors, Recipeints And Waiting Patients In U.S. From 2010 To 2015 33

Figure 10 Europe Hla Typing Transplant Diagnostics Services Market: Segmentation 36

Figure 11 Technological Advancements In Hla Typing, Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures Are Expected To Drive The Market For Europe Hla Typing Transplant Diagnostics Services In The Forecast Period 2018 To 2025 37

Figure 12 Polymerase Chain Reaction (Pcr) Segment Is Expected To Account For The Largest Share Of The Europe Hla Typing Transplant Diagnostics Services Market In 2018 & 2025 38

Figure 13 Asia Pacific Is The Highest Growing And Most Profitable Revenue Pockets For Hla Typing Transplant Diagnostics Services Manufacturers In The Forecast Period From 2018 To 2025 39

Figure 14 Europe Hla Typing Transplant Diagnostics Services Market: By Technology, 2017 41

Figure 15 Europe Hla Typing Transplant Diagnostics Services Market: By End-User, 2017 48

Figure 16 Europe Hla Typing Transplant Diagnostics Services Market: Snapshot (2017) 54

Figure 17 Europe Hla Typing Transplant Diagnostics Services Market: By Country (2017) 55

Figure 18 Europe Hla Typing Transplant Diagnostics Services Market : By Country (2018 & 2025) 57

Figure 19 Europe Hla Typing Transplant Diagnostics Services Market, By Country (2017 & 2025) 58

Figure 20 Europe Hla Typing Transplant Diagnostics Services Market, By Product (2018 & 2025) 59

Figure 21 Europe Hla Typing Transplant Diagnostics Services Market: Company Share 2017 (%) 84

?


List Of Table

Table List

Table 1 Cost Of Different Ngs Devices 31

Table 2 Europe Hla Typing Transplant Diagnostics Services Market, By Technology, 2016- 2025 (Usd Million) 42

Table 3 Europe Hla Typing Transplant Diagnostics Services Market, Next-Generation Sequencing (Ngs), By Region, 2016-2025 (Usd Million) 43

Table 4 Europe Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Technique, 2016-2025 (Usd Million) 44

Table 5 Europe Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Region, 2016-2025 (Usd Million) 45

Table 6 Europe Hla Typing Transplant Diagnostics Services Market, By End-User, 2016-2025 (Usd Million) 49

Table 7 Europe Hla Typing Transplant Diagnostics Services Market, Specialty Clinics, By Region, 2016-2025 (Usd Million) 50

Table 8 Europe Hla Typing Transplant Diagnostics Services Market, Hospitals, By Region, 2016-2025 (Usd Million) 51

Table 9 Europe Hla Typing Transplant Diagnostics Services Market, Transplant Centers, By Region, 2016-2025 (Usd Million) 52

Table 10 Europe Hla Typing Transplant Diagnostics Services Market, Academic Institutes, By Region, 2016-2025 (Usd Million) 53

Table 11 Europe Hla Typing Transplant Diagnostics Services Market, By Country, 2016-2025 (Usd Million) 60

Table 12 Europe Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 61

Table 13 Europe Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 61

Table 14 Europe Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 62

Table 15 Germany Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 63

Table 16 Germany Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 64

Table 17 Germany Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 64

Table 18 France Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 65

Table 19 France Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 66

Table 20 France Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 66

Table 21 U.K. Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 67

Table 22 U.K. Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 68

Table 23 U.K. Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 68

Table 24 Italy Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 69

Table 25 Italy Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 69

Table 26 Italy Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 70

Table 27 Spain Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 71

Table 28 Spain Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 71

Table 29 Spain Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 72

Table 30 Switzerland Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 73

Table 31 Switzerland Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 73

Table 32 Switzerland Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 74

Table 33 Netherlands Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 75

Table 34 Netherlands Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 75

Table 35 Netherlands Hla Typing Transplant Diagnostics Services Market, By End-User, 2016-2025 (Usd Million) 76

Table 36 Belgium Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 77

Table 37 Belgium Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 77

Table 38 Belgium Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 78

Table 39 Russia Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 79

Table 40 Russia Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 79

Table 41 Russia Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 80

Table 42 Turkey Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 81

Table 43 Turkey Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 81

Table 44 Turkey Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 82

Table 45 Rest Of Europe Hla Typing Transplant Diagnostics Services Market By Technology, 2016-2025 (Usd Million) 83

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Proimmune Ltd.

Creative Biolabs

Histogenetics LLC

The UCLA Immunogenetics Center

Admera Health, Quick Biology

New York Blood Center

The Sequencing Center

BloodCenter of Wisconsin

Laboratory Corporation of America Holdings

One Lambda (Thermo Fischer Scientific, InC.)